Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Antibodies Against the Insulin-like Growth Factor-1 Receptor (IGF-1R) in Graves' Disease and Graves' Orbitopathy

NCT03498417 is registered in ClinicalTrials.gov with University of Pisa as lead sponsor.

NCT NCT03498417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03498417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Antibodies Against the Insulin-like Growth Factor-1 Receptor (IGF-1R) in Graves' Disease and Graves' Orbitopathy
Lead sponsor
University of Pisa
Phase
Observational
Overall status
Completed
Start date
June 20, 2018
Completion date
July 20, 2018
Enrollment
135 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune thyroiditis, graves disease, graves ophthalmopathy